Page 28 - Chumakov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Po...

RPT - Gabon May Approve Other Russian-Made Vaccines After Sputnik V - Ambassador Thu 20th May 2021 | 11:10 AM MOSCOW (UrduPoint News / Sputnik - 20th May, 2021) Gabonmay approve other Russian-made vaccines after giving green light to Sputnik V, Gabonese Ambassador to Russia Johanna Rose Mamiaka told Sputnik on the sidelines of the Russia-Africa international conference. In February, Gabon registered Sputnik V under a fast-track procedure, thus becoming the 29th country in the world and the 4th nation in Africa to register the vaccine. So far the Russian vaccine has been registered in over 6...

Gabon May Approve Other Russian-Made Vaccines After Sputnik V - Ambassador Wed 19th May 2021 | 08:18 PM Gabon may approve other Russian-made vaccines after giving green light to Sputnik V, Gabonese Ambassador to Russia Johanna Rose Mamiaka told Sputnik on the sidelines of the Russia-Africa international conference MOSCOW (UrduPoint News / Sputnik - 19th May, 2021) Gabonmay approve other Russian-made vaccines after giving green light to Sputnik V, Gabonese Ambassador to Russia Johanna Rose Mamiaka told Sputnik on the sidelines of the Russia-Africa international conference. In February, Gabon...

Phase 3 clinical trials of CoviVac Covid-19 vaccine to start in June - developer MOSCOW. May 18 (Interfax) - The phase 3 clinical trials of the Covid-19 vaccine CoviVac will start in June and will take one year, and the need for three-dose vaccination for the elderly will be analyzed simultaneously, Aidar Ishmukhametov, director of the Russian Academy of Sciences' Chumakov Center, the vaccine's developer, told Interfax on Tuesday. "The phase 3 clinical trials will begin in June and will continue for a year," Ishmukhametov said. "As part of the phase 3 clinical trials, we will single out a sep...

A survey finds 42 percent of Russians are unwilling to be vaccinated against the Wuhan coronavirus under any circumstances.